These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 20730487)

  • 1. Body weight and risk of breast cancer in BRCA1/2 mutation carriers.
    Manders P; Pijpe A; Hooning MJ; Kluijt I; Vasen HF; Hoogerbrugge N; van Asperen CJ; Meijers-Heijboer H; Ausems MG; van Os TA; Gomez-Garcia EB; Brohet RM; ; van Leeuwen FE; Rookus MA
    Breast Cancer Res Treat; 2011 Feb; 126(1):193-202. PubMed ID: 20730487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy weight gain and premenopausal breast cancer risk.
    Hilakivi-Clarke L; Luoto R; Huttunen T; Koskenvuo M
    J Reprod Med; 2005 Nov; 50(11):811-6. PubMed ID: 16419626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers.
    Graeser MK; Engel C; Rhiem K; Gadzicki D; Bick U; Kast K; Froster UG; Schlehe B; Bechtold A; Arnold N; Preisler-Adams S; Nestle-Kraemling C; Zaino M; Loeffler M; Kiechle M; Meindl A; Varga D; Schmutzler RK
    J Clin Oncol; 2009 Dec; 27(35):5887-92. PubMed ID: 19858402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Energy balance and breast cancer risk: a prospective cohort study.
    Silvera SA; Jain M; Howe GR; Miller AB; Rohan TE
    Breast Cancer Res Treat; 2006 May; 97(1):97-106. PubMed ID: 16319973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
    J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraceptives and risk of ovarian and breast cancers in BRCA mutation carriers: a meta-analysis.
    Cibula D; Zikan M; Dusek L; Majek O
    Expert Rev Anticancer Ther; 2011 Aug; 11(8):1197-207. PubMed ID: 21916573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight gain prior to diagnosis and survival from breast cancer.
    Cleveland RJ; Eng SM; Abrahamson PE; Britton JA; Teitelbaum SL; Neugut AI; Gammon MD
    Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1803-11. PubMed ID: 17855698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers.
    Pijpe A; Manders P; Brohet RM; Collée JM; Verhoef S; Vasen HF; Hoogerbrugge N; van Asperen CJ; Dommering C; Ausems MG; Aalfs CM; Gomez-Garcia EB; ; Van't Veer LJ; van Leeuwen FE; Rookus MA
    Breast Cancer Res Treat; 2010 Feb; 120(1):235-44. PubMed ID: 19680614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers.
    Milne RL; Osorio A; Ramón y Cajal T; Baiget M; Lasa A; Diaz-Rubio E; de la Hoya M; Caldés T; Teulé A; Lázaro C; Blanco I; Balmaña J; Sánchez-Ollé G; Vega A; Blanco A; Chirivella I; Esteban Cardeñosa E; Durán M; Velasco E; Martínez de Dueñas E; Tejada MI; Miramar MD; Calvo MT; Guillén-Ponce C; Salazar R; San Román C; Urioste M; Benítez J
    Breast Cancer Res Treat; 2010 Jan; 119(1):221-32. PubMed ID: 19370414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anthropometry and female breast cancer: a prospective cohort study in urban Shanghai].
    Li HL; Gao YT; Li Q; Liu DK
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Jun; 27(6):488-93. PubMed ID: 17152508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age.
    van der Kolk DM; de Bock GH; Leegte BK; Schaapveld M; Mourits MJ; de Vries J; van der Hout AH; Oosterwijk JC
    Breast Cancer Res Treat; 2010 Dec; 124(3):643-51. PubMed ID: 20204502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA; Borofsky ND; Massardo S; Orentreich N
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations.
    Metcalfe K; Lubinski J; Lynch HT; Ghadirian P; Foulkes WD; Kim-Sing C; Neuhausen S; Tung N; Rosen B; Gronwald J; Ainsworth P; Sweet K; Eisen A; Sun P; Narod SA;
    J Natl Cancer Inst; 2010 Dec; 102(24):1874-8. PubMed ID: 21098759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium.
    Kast K; John EM; Hopper JL; Andrieu N; Noguès C; Mouret-Fourme E; Lasset C; Fricker JP; Berthet P; Mari V; Salle L; Schmidt MK; Ausems MGEM; Garcia EBG; van de Beek I; Wevers MR; Evans DG; Tischkowitz M; Lalloo F; Cook J; Izatt L; Tripathi V; Snape K; Musgrave H; Sharif S; Murray J; ; Colonna SV; Andrulis IL; Daly MB; Southey MC; de la Hoya M; Osorio A; Foretova L; Berkova D; Gerdes AM; Olah E; Jakubowska A; Singer CF; Tan Y; Augustinsson A; Rantala J; Simard J; Schmutzler RK; Milne RL; Phillips KA; Terry MB; Goldgar D; van Leeuwen FE; Mooij TM; Antoniou AC; Easton DF; Rookus MA; Engel C
    Breast Cancer Res; 2023 Jun; 25(1):72. PubMed ID: 37340476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer surgery trend changes since the introduction of BRCA1/2 mutation screening: a retrospective cohort analysis of 158 mutation carriers treated at a single institution.
    Mislowsky A; Domchek S; Stroede C; Bergey MR; Sonnad SS; Wu L; Tchou J
    Ann Surg Oncol; 2011 Mar; 18(3):745-51. PubMed ID: 20972632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.
    Furberg AS; Veierød MB; Wilsgaard T; Bernstein L; Thune I
    J Natl Cancer Inst; 2004 Aug; 96(15):1152-60. PubMed ID: 15292387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of body size in different periods of life and risk of premenopausal breast cancer.
    Weiderpass E; Braaten T; Magnusson C; Kumle M; Vainio H; Lund E; Adami HO
    Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1121-7. PubMed ID: 15247122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.
    Eisen A; Lubinski J; Klijn J; Moller P; Lynch HT; Offit K; Weber B; Rebbeck T; Neuhausen SL; Ghadirian P; Foulkes WD; Gershoni-Baruch R; Friedman E; Rennert G; Wagner T; Isaacs C; Kim-Sing C; Ainsworth P; Sun P; Narod SA
    J Clin Oncol; 2005 Oct; 23(30):7491-6. PubMed ID: 16234515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers.
    Metcalfe K; Lynch HT; Ghadirian P; Tung N; Kim-Sing C; Olopade OI; Domchek S; Eisen A; Foulkes WD; Rosen B; Vesprini D; Sun P; Narod SA
    Breast Cancer Res Treat; 2011 May; 127(1):287-96. PubMed ID: 21221768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weight, weight gain, and survival after breast cancer diagnosis.
    Kroenke CH; Chen WY; Rosner B; Holmes MD
    J Clin Oncol; 2005 Mar; 23(7):1370-8. PubMed ID: 15684320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.